Our observations provide a wider scope to the role PD-L1 plays on neutrophils in cancer, and highlight the therapeutic potential of blocking the PD-L1/PD-1 axis not only in propagating anti-tumor T cell responses, but also in facilitating neutrophil cytotoxicity. Here, PDCD1 is linked to neoplasm.